COVID-19 treatment in patients with comorbidities: Awareness of drug-drug interactions

Back, D.; Marzolini, C.; Hodge, C.; Marra, F.; Boyle, A.; Gibbons, S.; Burger, D.; Khoo, S.

doi:10.1111/bcp.14358

COVID-19 treatment in patients with comorbidities: Awareness of drug-drug interactions

Détails

Télécharger: Back.pdf (226.88 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY-NC 4.0

ID Serval

serval:BIB_BE885D4E98FF

Type

Article: article d'un périodique ou d'un magazine.

Sous-type

Editorial

Collection

Publications

Institution

UNIL/CHUV

Titre

COVID-19 treatment in patients with comorbidities: Awareness of drug-drug interactions

Périodique

Br J Clin Pharmacol

Auteur⸱e⸱s

Back D., Marzolini C., Hodge C., Marra F., Boyle A., Gibbons S., Burger D., Khoo S.

ISSN

1365-2125 (Electronic)
0306-5251 (Print)

ISSN-L

0306-5251

Statut éditorial

Publié

Date de publication

01/2021

Peer-reviewed

Oui

Volume

87

Numéro

1

Pages

212-213

Langue

anglais

Notes

Back, David
Marzolini, Catia
Hodge, Catherine
Marra, Fiona
Boyle, Alison
Gibbons, Sara
Burger, David
Khoo, Saye
eng
MR/V020498/1/MRC_/Medical Research Council/United Kingdom
Novartis/International
Abbvie/International
Comment
Letter
England
Br J Clin Pharmacol. 2021 Jan;87(1):212-213. doi: 10.1111/bcp.14358. Epub 2020 May 13.

Mots-clé

*Antiviral Agents, Comorbidity, Drug Interactions, Drug Repositioning, Humans, *Pharmaceutical Preparations, SARS-CoV-2, *COVID-19 Drug Treatment

URN

urn:nbn:ch:serval-BIB_BE885D4E98FF0

OAI-PMH

oai:serval.unil.ch:BIB_BE885D4E98FF

DOI

10.1111/bcp.14358

Pubmed

32384171

Création de la notice

25/08/2023 6:17